INDIANAPOLIS, March 21, 2016 -- PTS Diagnostics, the U.S.-based manufacturer of point-of-care biometric testing devices, including the CardioChek® family of analyzers, A1CNow® systems, and PTS Detect™ cotinine systems, announced today that they have signed a national sales and distribution agreement with Anda, an Allergan company. Anda is a national medical distribution company that sells over-the-counter pharmaceutical products to retail independent and chain pharmacies, nursing homes, mail-order pharmacies, hospitals, clinics and physician offices.
“Anda is well positioned with many of the key market segments that PTS Diagnostics’ portfolio of products serves,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “We are quite pleased Anda will become our newest distributor in the United States. Given our medical devices’ ability to measure point-of-care results for lipids (cholesterol), A1C, and cotinine as well as the ability to offer many more laboratory tests with a simple fingerstick, we anticipate significant further growth within the pharmacy, clinic and physician office settings.”
Founded in 1992, Anda is the fourth largest supplier of generic pharmaceuticals in the U.S., and is a premier distributor for new-to-market product launches to retail chains. With over 60,000 locations to sell to and 220 sales representatives making 18,000 telephone calls a day, Anda stocks more than 10,000 line items.
“Point-of-care testing is rapidly growing among pharmacies, hospitals, clinics and physician offices,” said Anthony Mihelich, Anda’s Vice President of Purchasing. “PTS Diagnostics CardioChek lipid analyzers, A1CNow+ systems and PTS Detect cotinine systems are prime for expansion within these markets. We stock the latest technologically advanced products that are in high demand with our customers. The PTS Diagnostics portfolio of products fills this market need nicely.”
PTS Diagnostics also offers critical information management functionality with digital capture and transfer of biometric screening information with its PTS Connect solutions. This suite of digital products make connectivity flexible and information management simple. In addition, the PTS Connect wellness solution provides an online account for wellness program participants to view biometric information and monitor ongoing health improvement.
About PTS Diagnostics
PTS Diagnostics is an innovative, global, point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decision. The company’s name represents the three pillars upon which it has built its long-term success: People, Technology and Service. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, distributes and markets products for distribution in more than 135 countries around the world. For more information, visit www.ptsdiagnostics.com or contact Tom Wiser at 317-870-5610 or [email protected].
Tom Wiser 317-517-2216


Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 



